(Q40678924)

22 September 2017

title

The effects of protease inhibitors on basal and insulin-stimulated lipid metabolism, insulin binding, and signaling (English)

1 reference

22 September 2017

Catarina Cammalleri

1

1 reference

22 September 2017

Ralph J Germinario

series ordinal

2

1 reference

22 September 2017

publication date

1 January 2003

1 reference

Journal of Lipid Research

22 September 2017

published in

1 reference

22 September 2017

volume

44

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

103-108

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Chemotherapeutic agents for human immunodeficiency virus infection: mechanism of action, pharmacokinetics, metabolism, and adverse reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Role of insulin resistance in human disease (syndrome X): an expanded definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Somatotropin antagonism of insulin-stimulated glucose utilization in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Synergistic antiadipogenic effects of HIV type 1 protease inhibitors with tumor necrosis factor alpha: suppression of extracellular insulin action mediated by extracellular matrix-degrading proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

The HIV protease inhibitor saquinavir impairs lipid metabolism and glucose transport in cultured adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Visceral abdominal-fat accumulation associated with use of indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Studies of body composition and fat distribution in HIV-infected and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

HIV protease inhibitors block adipogenesis and increase lipolysis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/RXR heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Enhanced insulin stimulation of sugar transport and DNA synthesis by glucocorticoids in cultured human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200245-JLR200

10.1194/JLR.M200245-JLR200

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference